Insulet Corporation (PODD)
USD 243.6
(-5.14%)
USD 243.6
(-5.14%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 798.1 Million USD | 9.76% |
| 2022 | 727.1 Million USD | 59.03% |
| 2021 | 457.2 Million USD | 375.75% |
| 2020 | 96.1 Million USD | -81.22% |
| 2019 | 511.8 Million USD | 68.89% |
| 2018 | 303.03 Million USD | 140.28% |
| 2017 | 126.11 Million USD | 265.91% |
| 2016 | 34.46 Million USD | -37.12% |
| 2015 | 54.81 Million USD | 133.81% |
| 2014 | 23.44 Million USD | 183.58% |
| 2013 | -28.04 Million USD | -146.08% |
| 2012 | 60.86 Million USD | 317.32% |
| 2011 | 14.58 Million USD | 133.27% |
| 2010 | -43.84 Million USD | -41.35% |
| 2009 | -31.01 Million USD | -209.46% |
| 2008 | 28.33 Million USD | 141.73% |
| 2007 | -67.91 Million USD | -1593.96% |
| 2006 | -4 Million USD | -289.01% |
| 2005 | 2.12 Million USD | 108.84% |
| 2004 | -23.98 Million USD | -455.66% |
| 2003 | -4.31 Million USD | 74.55% |
| 2002 | -16.96 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 682.3 Million USD | -3.16% |
| 2024 Q1 | 704.6 Million USD | -11.72% |
| 2023 Q4 | 798.1 Million USD | 8.59% |
| 2023 Q1 | 775.9 Million USD | 6.71% |
| 2023 Q2 | 737.7 Million USD | -4.92% |
| 2023 FY | 798.1 Million USD | 9.76% |
| 2023 Q3 | 735 Million USD | -0.37% |
| 2022 Q4 | 727.1 Million USD | 6.19% |
| 2022 FY | 727.1 Million USD | 59.03% |
| 2022 Q3 | 684.7 Million USD | -2.59% |
| 2022 Q1 | 706.6 Million USD | 54.55% |
| 2022 Q2 | 702.9 Million USD | -0.52% |
| 2021 Q4 | 457.2 Million USD | 14.33% |
| 2021 Q2 | 363.1 Million USD | 80.29% |
| 2021 Q1 | 201.4 Million USD | 109.57% |
| 2021 FY | 457.2 Million USD | 375.75% |
| 2021 Q3 | 399.9 Million USD | 10.13% |
| 2020 Q1 | 577.4 Million USD | 12.82% |
| 2020 Q3 | 24.8 Million USD | -62.31% |
| 2020 Q4 | 96.1 Million USD | 287.5% |
| 2020 Q2 | 65.8 Million USD | -88.6% |
| 2020 FY | 96.1 Million USD | -81.22% |
| 2019 Q4 | 511.8 Million USD | 34.59% |
| 2019 Q2 | 297.6 Million USD | -36.73% |
| 2019 Q3 | 380.26 Million USD | 27.78% |
| 2019 Q1 | 470.34 Million USD | 55.21% |
| 2019 FY | 511.8 Million USD | 68.89% |
| 2018 FY | 303.03 Million USD | 140.28% |
| 2018 Q4 | 303.03 Million USD | -33.82% |
| 2018 Q1 | 366.73 Million USD | 190.79% |
| 2018 Q2 | 440.87 Million USD | 20.22% |
| 2018 Q3 | 457.92 Million USD | 3.87% |
| 2017 FY | 126.11 Million USD | 265.91% |
| 2017 Q4 | 126.11 Million USD | 82.26% |
| 2017 Q3 | 69.19 Million USD | -15.85% |
| 2017 Q2 | 82.23 Million USD | -68.46% |
| 2017 Q1 | 260.72 Million USD | 656.45% |
| 2016 Q2 | 66.73 Million USD | 0.37% |
| 2016 Q4 | 34.46 Million USD | -69.93% |
| 2016 FY | 34.46 Million USD | -37.12% |
| 2016 Q1 | 66.49 Million USD | 21.31% |
| 2016 Q3 | 114.62 Million USD | 71.75% |
| 2015 Q4 | 54.81 Million USD | 54.48% |
| 2015 Q2 | 35.63 Million USD | 1.96% |
| 2015 FY | 54.81 Million USD | 133.81% |
| 2015 Q3 | 35.48 Million USD | -0.42% |
| 2015 Q1 | 34.94 Million USD | 49.07% |
| 2014 Q4 | 23.44 Million USD | -16.66% |
| 2014 FY | 23.44 Million USD | 183.58% |
| 2014 Q1 | -21.92 Million USD | 21.82% |
| 2014 Q2 | 25.92 Million USD | 218.23% |
| 2014 Q3 | 28.13 Million USD | 8.51% |
| 2013 Q1 | -27.14 Million USD | -144.6% |
| 2013 Q4 | -28.04 Million USD | 17.75% |
| 2013 Q3 | -34.1 Million USD | 10.23% |
| 2013 Q2 | -37.99 Million USD | -39.95% |
| 2013 FY | -28.04 Million USD | -146.08% |
| 2012 FY | 60.86 Million USD | 317.32% |
| 2012 Q1 | 27.83 Million USD | 90.87% |
| 2012 Q4 | 60.86 Million USD | 16.58% |
| 2012 Q3 | 52.2 Million USD | 21.17% |
| 2012 Q2 | 43.08 Million USD | 54.78% |
| 2011 Q4 | 14.58 Million USD | 481.77% |
| 2011 FY | 14.58 Million USD | 133.27% |
| 2011 Q3 | 2.5 Million USD | 197.59% |
| 2011 Q2 | -2.56 Million USD | 92.36% |
| 2011 Q1 | -33.63 Million USD | 23.29% |
| 2010 FY | -43.84 Million USD | -41.35% |
| 2010 Q1 | -20.12 Million USD | 35.13% |
| 2010 Q2 | -25.77 Million USD | -28.12% |
| 2010 Q3 | -9.73 Million USD | 62.22% |
| 2010 Q4 | -43.84 Million USD | -350.16% |
| 2009 Q1 | 13.28 Million USD | -53.13% |
| 2009 Q4 | -31.01 Million USD | -233.65% |
| 2009 Q3 | 23.2 Million USD | -24.45% |
| 2009 Q2 | 30.71 Million USD | 131.27% |
| 2009 FY | -31.01 Million USD | -209.46% |
| 2008 Q4 | 28.33 Million USD | 160.79% |
| 2008 Q2 | -14.1 Million USD | 71.22% |
| 2008 FY | 28.33 Million USD | 141.73% |
| 2008 Q1 | -49.02 Million USD | 27.81% |
| 2008 Q3 | 10.86 Million USD | 177.02% |
| 2007 Q1 | 10.14 Million USD | 353.16% |
| 2007 Q2 | -90.53 Million USD | -992.05% |
| 2007 Q3 | -74.86 Million USD | 17.3% |
| 2007 Q4 | -67.91 Million USD | 9.29% |
| 2007 FY | -67.91 Million USD | -1593.96% |
| 2006 Q4 | -4 Million USD | 75.1% |
| 2006 Q3 | -16.1 Million USD | 0.0% |
| 2006 FY | -4 Million USD | -289.01% |
| 2005 FY | 2.12 Million USD | 108.84% |
| 2005 Q4 | 2.12 Million USD | 0.0% |
| 2004 FY | -23.98 Million USD | -455.66% |
| 2003 FY | -4.31 Million USD | 74.55% |
| 2002 FY | -16.96 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | -2846.976% |
| BrainsWay Ltd. | -10.32 Million USD | 7833.527% |
| Cerus Corporation | 84.35 Million USD | -846.154% |
| Envoy Medical, Inc. | -3.81 Million USD | 21025.537% |
| electroCore, Inc. | -9.95 Million USD | 8117.077% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 15672.683% |
| IceCure Medical Ltd | -9.93 Million USD | 8134.025% |
| Inogen, Inc. | -103.56 Million USD | 870.597% |
| OrthoPediatrics Corp. | -9.26 Million USD | 8712.28% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 22019.802% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 6193.744% |
| MaxCyte, Inc. | -27.76 Million USD | 2974.689% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 15633.0% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 138715.1% |
| Orthofix Medical Inc. | 96.44 Million USD | -727.544% |
| PAVmed Inc | 29.08 Million USD | -2643.932% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 4811.612% |
| RxSight, Inc. | -6.68 Million USD | 12047.605% |
| Sight Sciences, Inc. | -102.71 Million USD | 877.004% |
| SI-BONE, Inc. | 5.72 Million USD | -13850.358% |
| TELA Bio, Inc. | -3.94 Million USD | 20310.18% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | -1292.334% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | -226632.955% |
| Acutus Medical, Inc. | 12.27 Million USD | -6399.715% |
| Talis Biomedical Corporation | -57.06 Million USD | 1498.605% |
| Spectral AI, Inc. | -3.5 Million USD | 22896.344% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 1761.774% |
| CVRx, Inc. | -59.95 Million USD | 1431.143% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | -40123.875% |
| PetVivo Holdings, Inc. | 1.27 Million USD | -62366.882% |
| Bioventus Inc. | 372.51 Million USD | -114.248% |
| Venus Concept Inc. | 74.3 Million USD | -974.144% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 7938.342% |
| LivaNova PLC | 62.53 Million USD | -1176.307% |
| 908 Devices Inc. | -115.09 Million USD | 793.421% |
| Alphatec Holdings, Inc. | 320.7 Million USD | -148.855% |
| Nemaura Medical Inc. | 9.92 Million USD | -7941.297% |
| NeuroPace, Inc. | 54.33 Million USD | -1368.797% |
| LENSAR, Inc. | -18.31 Million USD | 4458.344% |
| Apyx Medical Corporation | -5.15 Million USD | 15594.079% |
| Cutera, Inc. | 288.3 Million USD | -176.83% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | -10520.093% |
| BioSig Technologies, Inc. | 262 Thousand USD | -304518.321% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 1920.899% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 8775.943% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 43.207% |
| Axonics, Inc. | -77.19 Million USD | 1133.889% |
| Outset Medical, Inc. | 67.67 Million USD | -1079.243% |
| IRIDEX Corporation | -4.28 Million USD | 18712.407% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 548.325% |
| IRadimed Corporation | -47.71 Million USD | 1772.494% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 26474.752% |
| INVO Bioscience, Inc. | 8.45 Million USD | -9343.7% |
| Telesis Bio, Inc. | 32.63 Million USD | -2345.534% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 31996.798% |
| Varex Imaging Corporation | 316.9 Million USD | -151.846% |
| Quipt Home Medical Corp. | 81.73 Million USD | -876.454% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 28787.994% |
| Pulmonx Corporation | -42.36 Million USD | 1984.089% |
| Dynatronics Corporation | 6.2 Million USD | -12764.213% |
| Modular Medical, Inc. | -8.04 Million USD | 10024.148% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 18673.423% |
| Semler Scientific, Inc. | -57.13 Million USD | 1496.989% |
| InMode Ltd. | -135.39 Million USD | 689.465% |
| Bruker Corporation | 891.3 Million USD | 10.457% |
| Cytosorbents Corporation | 4.18 Million USD | -18984.102% |
| DexCom, Inc. | 2.02 Billion USD | 60.64% |
| Align Technology, Inc. | -840.47 Million USD | 194.959% |
| Viveve Medical, Inc. | -13.81 Million USD | 5877.89% |
| ZimVie Inc. | 450.41 Million USD | -77.191% |
| Movano Inc. | -5.86 Million USD | 13705.523% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 693.577% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 138715.1% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | -40123.875% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | -123.683% |
| Profound Medical Corp. | -18.17 Million USD | 4490.348% |
| enVVeno Medical Corporation | -2.21 Million USD | 36082.867% |
| Surmodics, Inc. | -12.01 Million USD | 6743.083% |
| iCAD, Inc. | -21.2 Million USD | 3863.025% |
| Nuwellis, Inc. | -2.81 Million USD | 28411.458% |
| Biotricity, Inc. | 23.09 Million USD | -3356.066% |
| iRhythm Technologies, Inc. | 93.65 Million USD | -752.207% |
| Aethlon Medical, Inc. | -4.5 Million USD | 17829.008% |
| InspireMD, Inc. | -8.04 Million USD | 10020.447% |
| PAVmed Inc. | 29.08 Million USD | -2643.932% |
| BIOLASE, Inc. | 11.34 Million USD | -6935.437% |
| Beyond Air, Inc. | 6.22 Million USD | -12712.651% |
| FONAR Corporation | -14.66 Million USD | 5542.089% |
| AxoGen, Inc. | 32.26 Million USD | -2373.502% |
| Vivani Medical, Inc. | 42 Thousand USD | -1900138.095% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 7588.272% |
| Inari Medical, Inc. | -7.16 Million USD | 11245.09% |
| UFP Technologies, Inc. | 40.77 Million USD | -1857.375% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | -25908.4% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 16827.062% |
| Tenon Medical, Inc. | -1.25 Million USD | 63693.625% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 10593.032% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 6791.927% |
| AdaptHealth Corp. | 2.21 Billion USD | 64.009% |
| Sintx Technologies, Inc. | 905 Thousand USD | -88087.845% |
| NanoVibronix, Inc. | -3.27 Million USD | 24447.163% |
| Quanterix Corporation | -132.95 Million USD | 700.265% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 28787.994% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 3668.522% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | -5.888% |
| TransMedics Group, Inc. | 121.13 Million USD | -558.857% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 3148.51% |
| NeuroMetrix, Inc. | -1.49 Million USD | 53625.321% |
| Hyperfine, Inc. | -75.61 Million USD | 1155.423% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | -424.414% |
| Biomerica, Inc. | -3.38 Million USD | 23677.548% |
| Bone Biologics Corporation | -3.02 Million USD | 26469.794% |
| AVITA Medical, Inc. | -26.23 Million USD | 3142.512% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 43512.49% |
| Silk Road Medical, Inc | 64.42 Million USD | -1138.843% |